| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 11201 | 2021 |
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The lancet oncology 18 (10), 1373-1385, 2017 | 1060 | 2017 |
| Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction DH Kim, EA Rozhkova, IV Ulasov, SD Bader, T Rajh, MS Lesniak, ... Nature materials 9 (2), 165-171, 2010 | 715 | 2010 |
| Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors DA Wainwright, AL Chang, M Dey, IV Balyasnikova, CK Kim, A Tobias, ... Clinical cancer research 20 (20), 5290-5301, 2014 | 649 | 2014 |
| CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells AL Chang, J Miska, DA Wainwright, M Dey, CV Rivetta, D Yu, D Kanojia, ... Cancer research 76 (19), 5671-5682, 2016 | 600 | 2016 |
| IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival DA Wainwright, IV Balyasnikova, AL Chang, AU Ahmed, KS Moon, ... Clinical cancer research 18 (22), 6110-6121, 2012 | 490 | 2012 |
| Chemokines in tumor progression and metastasis PJ Sarvaiya, D Guo, I Ulasov, P Gabikian, MS Lesniak Oncotarget 4 (12), 2171, 2013 | 425 | 2013 |
| Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy B Auffinger, AL Tobias, Y Han, G Lee, D Guo, M Dey, MS Lesniak, ... Cell Death & Differentiation 21 (7), 1119-1131, 2014 | 393 | 2014 |
| Multifunctional nanoparticles for brain tumor imaging and therapy Y Cheng, RA Morshed, B Auffinger, AL Tobias, MS Lesniak Advanced drug delivery reviews 66, 42-57, 2014 | 369 | 2014 |
| An increase in CD4+ CD25+ FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme AE Andaloussi, MS Lesniak Neuro-oncology 8 (3), 234-243, 2006 | 346 | 2006 |
| A high-performance nanobio photocatalyst for targeted brain cancer therapy EA Rozhkova, I Ulasov, B Lai, NM Dimitrijevic, MS Lesniak, T Rajh Nano letters 9 (9), 3337-3342, 2009 | 323 | 2009 |
| The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence B Auffinger, D Spencer, P Pytel, AU Ahmed, MS Lesniak Expert review of neurotherapeutics 15 (7), 741-752, 2015 | 314 | 2015 |
| Targeted therapy for brain tumours MS Lesniak, H Brem Nature reviews Drug discovery 3 (6), 499-508, 2004 | 308 | 2004 |
| Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma AM Sonabend, IV Ulasov, MA Tyler, AA Rivera, JM Mathis, MS Lesniak Stem cells 26 (3), 831-841, 2008 | 302 | 2008 |
| HIF-1α is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of Tregs in glioblastoma J Miska, C Lee-Chang, A Rashidi, ME Muroski, AL Chang, ... Cell Reports 27 (1), 226-237. e4, 2019 | 293 | 2019 |
| Blood‐brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging Y Cheng, Q Dai, RA Morshed, X Fan, ML Wegscheid, DA Wainwright, ... Small 10 (24), 5137-5150, 2014 | 290 | 2014 |
| Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD133+ Glioma Stem Cells to Temozolomide Therapy IV Ulasov, S Nandi, M Dey, AM Sonabend, MS Lesniak Molecular medicine 17, 103-112, 2011 | 245 | 2011 |
| WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer P Wend, S Runke, K Wend, B Anchondo, M Yesayan, M Jardon, N Hardie, ... EMBO molecular medicine 5 (2), 264-279, 2013 | 213 | 2013 |
| Local delivery of doxorubicin for the treatment of malignant brain tumors in rats MS Lesniak, U Upadhyay, R Goodwin, B Tyler, H Brem Anticancer research 25 (6B), 3825-3831, 2005 | 196 | 2005 |
| Prolongation of survival following depletion of CD4+ CD25+ regulatory T cells in mice with experimental brain tumors A El Andaloussi, YU Han, MS Lesniak Journal of neurosurgery 105 (3), 430-437, 2006 | 181 | 2006 |